• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CTI BioPharma Corp

+ Add to Watchlist

CEPR:GR

1.859 EUR 0.142 7.10%

As of 15:14:53 ET on 12/23/2014.

Snapshot for CTI BioPharma Corp (CEPR)

Open: 1.914 Day's Range: 1.859 - 1.962 Volume: 1,300
Previous Close: 2.001 52wk Range: 1.333 - 3.549 1-Yr Rtn: +44.44%

Stock Chart for CEPR

No chart data available.
  • CEPR:GR 1.901
  • 1D
  • 1M
  • 1Y
2.001
Interactive CEPR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CEPR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.5470
Est. PEG Ratio -
Market Cap (M EUR) 328.11
Shares Outstanding (M) 176.50
30 Day Average Volume 2,637
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CEPR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CEPR

CTI BioPharma Corp. is a biopharmaceutical company which provides medical research services. The Company develops and commercializes clinical treatment and drugs for various cancers such as ovarian, brain, neck, and breast.

James A BiancoPresident/CEO/Co-FounderLouis A BiancoExec VP/Chief Governance Ofcr
Jack W SingerExec VP:Global Medical AffairsMatthew J PlunkettExec VP:Corporate Development
More Company Profile & Key Executives for CEPR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil